Aurinia Pharmaceuticals (AUPH) had the highest return in 2022 and on October 20, 2022 by a mid-cap US stock or mid-cap US stock, returning 13.2%.
| ASSET | % RETURN |
|---|---|
Aurinia Pharmaceuticals (AUPH) | 13.21% |
CareDx (CDNA) | 10.33% |
Par Pacific (PARR) | 9.46% |
Century Aluminum (CENX) | 9.42% |
Cohen & Steers (CNS) | 8.62% |
Wix (WIX) | 8.34% |
Zai Lab (ZLAB) | 6.51% |
Viking Therapeutics (VKTX) | 5.63% |
Youdao (DAO) | 5.57% |
Denali Therapeutics (DNLI) | 5.45% |
Recursion Pharmaceuticals (RXRX) | 5.41% |
Rigetti Computing (RGTI) | 5.32% |
Cellebrite DI (CLBT) | 5.28% |
Aveanna Healthcare (AVAH) | 5.11% |
Constellium (CSTM) | 5.06% |
First Majestic Silver (AG) | 4.95% |
Ringcentral (RNG) | 4.79% |
Navitas Semiconductor (NVTS) | 4.75% |
Appian (APPN) | 4.75% |
HUTCHMED DRC (HCM) | 4.68% |
Edgewise Therapeutics (EWTX) | 4.51% |
PTC Therapeutics (PTCT) | 4.51% |
Kodiak Sciences (KOD) | 4.48% |
Kingsoft Cloud Holdings (KC) | 4.44% |
Hims Hers Health (HIMS) | 4.39% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.